| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/17/1995 | CA2128164A1 Process for the preparation of high purity buspiron and the hydrochloride thereof |
| 01/17/1995 | CA2128160A1 Cation-complexed polysaccharides |
| 01/17/1995 | CA2128139A1 Mdr reversal agents |
| 01/17/1995 | CA1334008C Photoprotection compositions comprising chelating agents |
| 01/17/1995 | CA1334004C Essential fatty acid compositions |
| 01/17/1995 | CA1334003C Skin improving composition containing gla or dgla |
| 01/17/1995 | CA1334002C Essential fatty acid compositions and methods for the modulation of prostaglandin levels in mammals |
| 01/17/1995 | CA1334001C Stable pharmaceutical composition containing esmolol |
| 01/17/1995 | CA1334000C Coated veterinary implant comprising melatonin |
| 01/17/1995 | CA1333999C Drug and method for increasing the microcirculatory flow-rate and volume in the capillaries to the skin |
| 01/17/1995 | CA1333997C Cholesterol-lowering combination compositions of guar gum and niacin |
| 01/17/1995 | CA1333996C Dhp delayed release preparation |
| 01/17/1995 | CA1333995C Brain neuron protecting agent containing a dihydropyridine compound |
| 01/14/1995 | CA2127900A1 Antianemic composition for veterinary use |
| 01/14/1995 | CA2127735A1 Pyrimidones and imidazolinones for treatment of shock |
| 01/12/1995 | WO1995001447A1 Retroviral vector for the transfer and expression of genes for therapeutical purposes in eucaryotic cells |
| 01/12/1995 | WO1995001429A1 Pharmaceutical compositions and their use, namely for the treatment of neurodegenerative diseases |
| 01/12/1995 | WO1995001370A1 Higher order structure and binding of peptide nucleic acids |
| 01/12/1995 | WO1995001369A1 Double-stranded peptide nucleic acids |
| 01/12/1995 | WO1995001366A1 Fluorinated 6-methylenandrosta-1,4-dien-3-one derivatives and process for their preparation |
| 01/12/1995 | WO1995001364A1 Chemically modified oligonucleotide for site-directed mutagenesis |
| 01/12/1995 | WO1995001363A1 Methylphosphonic acid ester, process for preparing the same and its use |
| 01/12/1995 | WO1995001362A1 Liponucleotides of desoxynucleosides, their preaparation and their use as anti-viral drugs |
| 01/12/1995 | WO1995001354A1 Pharmacologically active enantiomers |
| 01/12/1995 | WO1995001353A1 Antihypertensive tricyclic azepine derivatives useful as inhibitors of enkephalinase and ace |
| 01/12/1995 | WO1995001351A1 Substituted arylthioalkylthiopyridines |
| 01/12/1995 | WO1995001350A1 Tetrazole derivatives having antihistaminic and antiallergic activity |
| 01/12/1995 | WO1995001349A1 Arylidene and heteroarylidene oxindole derivatives as tyrosine kinase inhibitors |
| 01/12/1995 | WO1995001348A2 Imides as inhibitors of tnp alpha |
| 01/12/1995 | WO1995001343A1 Pyridazinone derivatives with pharmaceutical activity |
| 01/12/1995 | WO1995001342A1 Ansamycin derivatives as antioncogene and anticancer agents |
| 01/12/1995 | WO1995001338A1 Fluoroalkoxy-substituted benzamides and their use as cyclic nucleotide phosphodiesterase inhibitors |
| 01/12/1995 | WO1995001333A1 Acetamide derivatives and their use for modifying feeding behaviour modifiers |
| 01/12/1995 | WO1995001326A1 Anti-atherosclerotic diaryl compounds |
| 01/12/1995 | WO1995001324A1 Salmeterol xinafoate with controlled particle size |
| 01/12/1995 | WO1995001321A1 Neomorphic ibuprofen and methods of using same |
| 01/12/1995 | WO1995001180A1 Hormonal agent for the treatment of acne and its use |
| 01/12/1995 | WO1995001179A1 Modulation of inflammation related to columnar epithelia |
| 01/12/1995 | WO1995001178A1 Antitussive |
| 01/12/1995 | WO1995001177A1 Medicaments containing vapiprost hydrochloride for the treatment of inflammatory diseases |
| 01/12/1995 | WO1995001176A1 Use of an angiotensin ii antagonist as an ocular hypotensive agent |
| 01/12/1995 | WO1995001175A1 Immunosuppressant and antiallergic compounds, e.g. n-(3-oxohexanoyl) homoserine lactone |
| 01/12/1995 | WO1995001174A1 Use of rosmanol derivatives for producing antiradical and/or antilipoperoxidative and/or hepatotropic drugs |
| 01/12/1995 | WO1995001173A1 Amphoteric surfactant for the treatment of aphthous ulcers |
| 01/12/1995 | WO1995001172A1 Amino acid supplement |
| 01/12/1995 | WO1995001171A1 Use of acetamide derivatives for modifying feeding behaviour |
| 01/12/1995 | WO1995001170A2 Use of phenethanolamine derivatives in the treatment of gastrointestinal disorders |
| 01/12/1995 | WO1995001169A1 Neurotropic agent and process for producing it |
| 01/12/1995 | WO1995001168A2 Pharmaceutical preparations that contain an active substance with modified amidine groups |
| 01/12/1995 | WO1995001166A1 Encapsulated medicine |
| 01/12/1995 | WO1995001162A1 Pharmaceutical emulsions containing bioactive steroids |
| 01/12/1995 | WO1995001161A1 Pack for use in, and method of hormonal replacement therapy |
| 01/12/1995 | WO1995001160A1 Stable topical retinoid compositions |
| 01/12/1995 | WO1995001157A1 Use of hydroxyphenyl oximes as chelating photoprotectants |
| 01/12/1995 | WO1995001097A1 Nucleotide preparation and uses thereof in wound healing |
| 01/12/1995 | WO1995001096A1 Pharmaceutical compositions and use thereof for treatment of neurological diseases and etiologically related symptomology |
| 01/12/1995 | WO1994023691A3 Oral compositions for treating plaque and gingivitis containing a noncationic antibacterial agent and a bicarbonate salt |
| 01/12/1995 | DE4422938A1 Soft gelatin capsules |
| 01/12/1995 | DE4323174A1 Pharmaceutical and/or cosmetic composition, and the use of a composition of this type |
| 01/12/1995 | DE4322057A1 Tablet with improved bioavailability containing dichloromethylenediphosphonic acid as active ingredient |
| 01/12/1995 | CA2626178A1 Process for the preparation of thalidomide |
| 01/12/1995 | CA2531868A1 Process for the preparation of thalidomide |
| 01/12/1995 | CA2166477A1 Neurotropic agent and process for producing it |
| 01/12/1995 | CA2166462A1 Double-stranded peptide nucleic acids |
| 01/12/1995 | CA2166461A1 Higher order structure and binding of peptide nucleic acids |
| 01/12/1995 | CA2166460A1 Neomorphic ibuprofen and methods of using same |
| 01/12/1995 | CA2166413A1 Anti-atherosclerotic diaryl compounds |
| 01/12/1995 | CA2166383A1 Pharmaceutical compositions and use thereof for treatment of neurological diseases and etiologically related symptomology |
| 01/12/1995 | CA2166327A1 Substituted arylthioalkylthiopyridines |
| 01/12/1995 | CA2166320A1 Ansamycin derivatives as antioncogene and anticancer agents |
| 01/12/1995 | CA2166289A1 Immunosuppressant and antiallergic compounds e.g. n-(3-oxohexanoyl) homoserine lactone |
| 01/12/1995 | CA2166128A1 Acetamide derivatives and their use for modifying feeding behaviour modifiers |
| 01/12/1995 | CA2166121A1 Hormonal method of acne therapy |
| 01/12/1995 | CA2165979A1 Liponucleotides of deoxynucleosides, the production thereof and their use as antiviral pharmaceutical agents |
| 01/12/1995 | CA2165792A1 Tetrazole derivatives |
| 01/12/1995 | CA2165789A1 Encapsulated medicine |
| 01/12/1995 | CA2143667A1 Pharmaceutical emulsions containing bioactive steroids |
| 01/12/1995 | CA2143620A1 Retroviral vector for the transfer and expression of genes for therapeutical purposes in eucaryotic cells |
| 01/12/1995 | CA2143318A1 Antitussive agents |
| 01/12/1995 | CA2142472A1 Arylidene and heteroarylidene oxindole derivatives and process for their preparation |
| 01/11/1995 | EP0633261A1 Quinoline-3-acetic acid derivative, process for producing the same, and use thereof |
| 01/11/1995 | EP0633260A1 2,3-Dihydro-1,4-benzodioxin-5-yl-piperazine derivatives having 5-HT1A-antagonistic activity |
| 01/11/1995 | EP0633259A1 Sulfonylaminopyrimidines, their preparation and their use as medicine |
| 01/11/1995 | EP0633256A1 Benzopyran and related compounds |
| 01/11/1995 | EP0633251A1 Derivatives of 9-aminoacridine having psychotropic, antiamnestic and lipid regulating properties |
| 01/11/1995 | EP0633248A1 Butenoic acid derivatives |
| 01/11/1995 | EP0633247A1 2-Bromo- and 2-nitroxy derivatives of 3-bromo- and 3,3-dibromo-4-oxo-azetidines, processes for the preparation thereof and use thereof |
| 01/11/1995 | EP0633026A1 Use of imidazole derivative for antihypertensive agent |
| 01/11/1995 | EP0633025A1 Pharmaceutical composition containing 3-methyl-1-phenyl-2-pyrazolin-5-one for the treatment of ophthalmological diseases |
| 01/11/1995 | EP0633024A1 Topically administrable zinc phthalocyanine compositions |
| 01/11/1995 | EP0633023A2 Preventing emesis and treating sexual dysfunction using tetrahydrobenz CD indole-6-carboxamides |
| 01/11/1995 | EP0633022A2 Chondroprotective flavones |
| 01/11/1995 | EP0633021A1 Chondroprotective agents |
| 01/11/1995 | EP0633017A2 Cosmetic and dermatologic compositions containing delta-aminolevulinic acid |
| 01/11/1995 | EP0632813A1 Amadori reaction compounds and products, process for their manufacture, and their use |
| 01/11/1995 | EP0632809A1 Quinuclidine derivatives as substance p antagonists |
| 01/11/1995 | EP0632808A1 Antiviral peptides |
| 01/11/1995 | EP0632805A1 Melamine derivatives for use in the treatment of cancer |
| 01/11/1995 | EP0632794A1 Method for separating enantiomers of aryloxipropanolamine derivatives, and chiral solid-phase chromatography material for use in the method |
| 01/11/1995 | EP0632726A1 A method for treating kaposi's sarcoma and blocking or inhibiting vascular permeability |